Maryland State Retirement & Pension System’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
19,170
-617
-3% -$25.3K 0.02% 545
2026
Q1
$657K Sell
19,787
-112
-0.6% -$3.34K 0.01% 671
2025
Q4
$593K Buy
19,899
+393
+2% +$12.8K 0.01% 725
2025
Q3
$705K Sell
19,506
-20,347
-51% -$670K 0.01% 629
2025
Q2
$1.43M Buy
39,853
+936
+2% +$34.8K 0.03% 421
2025
Q1
$1.53M Sell
38,917
-6,131
-14% -$206K 0.04% 371
2024
Q4
$1.36M Sell
45,048
-3
-0% -$86 0.03% 485
2024
Q3
$1.05M Buy
+45,051
New +$984K 0.02% 629

Other funds holding TGTX

Maryland State Retirement & Pension System's TGTX Position: Q2 2026 in Review

Maryland State Retirement & Pension System reduced its TG Therapeutics (TGTX) stake by 3.1% in Q2 2026, selling an estimated $25.3K and leaving 19,170 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #545.

Maryland State Retirement & Pension System first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.53M in Q1 2025. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Maryland State Retirement & Pension System held 19,170 shares of TG Therapeutics worth $1.05M as of Q2 2026.
  • Maryland State Retirement & Pension System sold 617 TG Therapeutics shares in Q2 2026, an estimated $25.3K.
  • TG Therapeutics made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #545 holding.
  • Maryland State Retirement & Pension System first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Maryland State Retirement & Pension System's TG Therapeutics position peaked at $1.53M in Q1 2025.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.